dpp 4 inhibitor glp 1 agonist It's the first in a class of drugs called DPP-4 inhibitors Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)

These agents, comprising GLP-1 combined molecules with glucagon or other hormones, have been investigated in preclinical studies for NAFLD treatment

The reduction in oestrogen typically causes a redistribution of adipose tissue from peripheral sites (hips and thighs) to central abdominal areas, increasing visceral fat accumulation

These drugs are particularly effective in patients with T2DM or obesity, improving skin symptoms through weight loss, better blood sugar control, and immune system regulation in psoriatic plaques

and potentially slowing the progression of dementia

Thus, GLP-1RA mediates inflammation to prevent formation of neurotoxic astrocytes which cause RGC death

We categorised K6 scores as no/low distress (04) or moderate/severe distress ( 5) [35, 37]